In hepatocellular carcinoma (HCC) cells, the inhibition of PCK1 reduced the phosphorylation of INSIG (insulin-induced gene) 1/2, leading to a suppression of cell proliferation and a decrease in tumorigenesis [27, 29]. Here, PCK1 is linked to hepatocellular carcinoma.